Anpario (ANP) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record first-half revenue of £17.0m, up 11% year-over-year, driven by strong sales in Asia, Middle East & Africa, and Europe, offsetting declines in the US and Australasia.
Gross profit rose 20% to £8.1m, with gross margin improving to 47.5% from 43.9% due to higher volumes and production efficiencies.
Adjusted EBITDA increased 41% to £2.7m, and profit before tax rose 53% to £2.1m.
Diluted adjusted EPS surged 84% to 10.39p, reflecting both profit growth and a reduced share count after a £9m tender offer in 2023.
Interim dividend increased by 2% to 3.25p per share, supported by improved profits.
Financial highlights
Revenue: £17.0m (+11% YoY); Gross profit: £8.1m (+20% YoY); Gross margin: 47.5% (+3.6pp YoY).
Adjusted EBITDA: £2.7m (+41% YoY); Profit before tax: £2.1m (+53% YoY).
Diluted adjusted EPS: 10.39p (+84% YoY); Cash and equivalents: £13.5m (+85% YoY).
Net assets: £35.4m, up £1.8m from FY 2023, reflecting share buybacks.
Administrative expenses rose 11% due to inflation and increased costs, partially offset by restructuring savings.
Outlook and guidance
Strong start to H2 with accelerating sales and volume growth; profitability expected to improve further.
Management targets high single-digit annual sales growth, supported by operational gearing and acquisitions.
Focus on expanding into ruminant, aquaculture, and pet segments to diversify revenue.
Management does not publish formal revenue or margin guidance but expects continued sales volume recovery and margin protection into 2025.
Visibility to year-end is limited due to order timing and logistics, with sales cutoffs potentially impacting reported results.
Latest events from Anpario
- Revenue and margin surged, supported by Bio-Vet acquisition and broad segment recovery.ANP
H2 20248 Jul 2026 - Record revenue, profit, and margin growth in 2025, with strong cash and dividend increases.ANP
H2 20251 Jun 2026 - Revenue up 34%, profit before tax up 62%, and gross margin at 51.4% year-over-year.ANP
H1 202531 Mar 2026 - FY 2024 revenue and EBITDA are set to surpass expectations, driven by robust sales and acquisitions.ANP
Q4 2024 TU31 Mar 2026 - FY 2025 revenue and EBITDA surpassed expectations, driven by broad-based and Bio-Vet growth.ANP
Q4 2025 TU31 Mar 2026